top of page
Report.png
Lateral Flow Assay Components Market

Lateral Flow Assay Component Market Size, Share, Competitive Landscape and Trend Analysis Report By Product Type, Technique, Application and End User: Global Opportunity and Industry Forecast (2025-2032)

Report ID:

1169

Industry:

Healthcare

Published on:

March 2026

Global Lateral Flow Assay Component Market had a value of USD 9.02 Billion in 2025 and expected it to hit USD 14.74 Billion by 2032, with a CAGR of 7.54 % during the forecast period.

Lateral Flow Assay Component Trends and Analytical Insights -

  • North America Lateral Flow Assay Component Market was the largest revenue generating region market in year 2025, with market share accounted for 34.22%.

  • In 2025, Product Type segment, Membrane dominated the Lateral Flow Assay Component, accounted for 38.12% market shares.

  • Leading Key players for Lateral Flow Assay Component Market in 2025 was Abbott Laboratories, Ahlstrom, Bio-Rad Laboratories and Becton, Dickinson and Company (BD)

Lateral Flow Assay Component Market Size & Forecast

  • Market Size 2025: USD 9.02 Billion

  • Projected Market Size 2032: USD 14.74 Billion

  • CAGR (2025-2032): 7.54%

  • North America: Dominating market in 2025

Lateral Flow Assay Component Market Overview

The lateral flow assay component market refers to the segment of the market involved with the manufacturing and supply of basic materials for rapid diagnostic tests. These materials can be pads, membranes, strips or detection systems and are used to support a wide variety of applications including: medical diagnostics, veterinary screening, food safety testing and environmental testing. In 2025, an estimated 5.8 billion rapid test units will be produced worldwide; approximately 64% of these will utilize lateral flow assay formats. The lateral flow assay component market is expected to show a steady rate of growth as a result of the increase in acceptance by health care practitioners of point-of-care testing solutions over the period from 2021 through 2025. Production facilities are projected to operate at utilization rates greater than 78% during this timeframe. Manufacturers are also expected to experience an increase in their use of technological integration, with manufacturers focusing on development efforts around improving test sensitivity by 15% relative to previous product generations.

Another factor impacting the lateral flow assay component market was the increasing adoption of home use diagnostic tests. Self-testing kits contributed almost 40% of all global rapid diagnostics consumption in 2023. Membranes produced annually are coming in at over 1.2 billion square meters, of which greater than 55% of these membranes are made from nitrocellulose. In addition to those factors, investments in biotechnology continued to grow at approximately 12% per year between 2020 and 2025. Hospitals and diagnostic laboratories were integrating lateral flow technologies as part of regular screening programs. Supply chains were getting more efficient and automation within component assembly lines is increasing productivity by up to 18% during this timeframe.

Lateral Flow Assay Component Market Dynamic’s

An increased need for convenient and efficient ways to diagnose patients was helping to drive growth within the global Lateral Flow Assay Component market. The rise in infectious disease testing was increasing the number of tests conducted globally by nearly 20% each year from 2020 to 2025. Several healthcare facilities were focusing their efforts on delivering fast results, often within 15 minutes per test. In 2022 alone, approximately 2 billion rapid test kits were being distributed through various governmental screening programs. The Lateral Flow Assay Component market was gaining more momentum as research institutes were increasing the use of assay strips for field-based studies. The aging population was also contributing to higher demand for chronic disease management, and diabetes testing kits were growing at a rate of 11% annually. Additionally, the increased use of automation in production was reducing manufacturing errors by 9%, which was improving product consistency. With rising awareness of early disease identification, test kits were being used more widely in both urban and semi-urban healthcare settings where medical services were available to the population.

Price volatility for raw materials poses certain challenges for the Lateral Flow Assay Component Market (LFACM), such as: an increase of almost 8% per year on average for nitrocellulose prices from 2021-2023 (compared to the inflation rate); an increase in the cost of compliance related to quality control requirements by approximately 10% each year; etc. Opportunities exist within the LFACM due to advances in multiplex detection technologies. Multiplex assays allow detection of 3 - 5 biomarkers using one assay, leading to increased efficiency of diagnostics of approximately 25%. Digital readers improve diagnostic accuracy by approximately 18% as compared to reading results visually; etc. Emerging economies are continuing to raise infrastructure expenditures on health care by around 14% per year to enable distribution of diagnostic testing kits in rural areas. Manufacturers are also focused on using biodegradable materials to reduce their impact on the environment, which has resulted in approximately 12% less waste reported by pilot projects to date.

From 2022 to 2025, the Lateral Flow Assay Component Market was observing strategic collaborations between biotech firms and component suppliers. Nearly 35 new product variants were being launched in 2023 alone. Companies were introducing membranes with improved pore size control, enhancing sensitivity by up to 20%. The Lateral Flow Assay Component Market was also integrating AI-enabled readers, which were reducing interpretation errors by 16%. Production capacities for absorbent pads were increasing by 22% between 2021 and 2025. Several manufacturers were adopting ISO 13485 certification standards to strengthen quality systems. Investment in R&D activities was rising by 13% annually, and partnerships with academic institutes were accelerating prototype development timelines by 30%.

Lateral Flow Assay Component Market Segment Analysis

The Lateral Flow Assay Component Market is segmented into By Product Type, Type, Technique, Application and End User.

By Product Type,

The Lateral Flow Assay Component market was divided into four product categories: Pads, Membranes, Lateral Flow Test Stripes and Readers, and Others. In 2025, the Membranes category represented the largest share of the total Lateral Flow Assay Component market at 38.12%. Membranes are integral to controlling the sample flow and the sensitivity of the assay reaction; Nitrocellulose membranes provide consistent capillary action for accurate detection. Worldwide demand is driving 15% annual growth in membrane production. The Lateral Flow Assay Component market is seeing increased advancement in the development and procurement of membranes with uniform pore size distribution. Manufacturers are striving to enhance protein binding capability in their membranes by approximately 12% in order to enhance assay reliability.

By Technique,

Based on Technique the Lateral Flow Assay Component Market is divided into Sandwich Assays, Multiplex Detection Assays, and Competitive Assays. The Sandwich Assay segment was the market leader of the Lateral Flow Assay Component Market and contributed to 46.11% of the overall Lateral Flow Assay Component Market in 2025. The high specificity of Sandwich Assays, as well as their widespread use to diagnose infectious diseases, contributed to this growth. Improved antibody pairings, as well as improvements in the sensitivity of these assays (up to 18%), has led to increased use of Sandwich Assays in hospital laboratories. Additionally, Sandwich Assays were being utilized for both quantitative and qualitative testing with an average test turnaround time of just under 20 minutes. More and more research institutions were using Sandwich Assays in biomarker validation studies.

Lateral Flow Assay Component Market Region Analysis

In 2025, North America was accounting for 34.22% of the total share of the Lateral Flow Assay Components market, leading all other regions. The region was making significant investments into the development of a strong diagnostic infrastructure and was adopting point-of-care testing at an increasing rate over the past few years. In 2023, annual healthcare expenditures were reaching over $4 trillion, which was considerably aiding the large-volume purchasing of rapid test kits. The strong presence of advanced biotechnology research programs in both the United States and Canada was also contributing positively to the growth of the Lateral Flow Assay Components market, as the average number of rapid diagnostic products attaining regulatory approval was increasing between 2022 and 2025, with more than 50 new products receiving regulatory clearance during this period. Additionally, the availability of skilled labor, along with automated manufacturing facilities, was strengthening the capabilities for manufacturing components throughout the region.

Lateral Flow Assay Component Market Competitive Analysis

The Lateral Flow Assay Component Market was having many well-known companies operating within the industry, and they were all trying to create new ideas or were working with other businesses through collaborations and partnerships. Each year, these companies were spending between 12–15% of their total sales on research activities, while they were also enhancing the sensitivity of membranes and improving the accuracy of readers. Additionally, several businesses were merging or were establishing new agreements with each other to develop stronger global supply chains. From 2021 to 2025, firms were increasing their production capacity by about 20% per firm as demand for their products was rising. As producers were diversifying their product portfolios and were obtaining official certifications, they were strengthening their competitive positions in the Lateral Flow Assay Component Market.

Lateral Flow Assay Component Market Scope:

Lateral Flow Assay Component Market Key Players –

  • Abbott Laboratories

  • Ahlstrom

  • Bio-Rad Laboratories

  • Becton, Dickinson and Company (BD)

  • Cobetter Filtration Equipment Co., Ltd.

  • Danaher Corporation

  • Merck KGaA

  • PerkinElmer, Inc.

  • QIAGEN N.V.

  • QuidelOrtho Corporation

  • Roche Diagnostics

  • Sartorius AG

  • Thermo Fisher Scientific Inc.

  • Cytiva (Whatman)

  • Advanced Microdevices Pvt. Ltd.

Frequently Ask Questions –

1)    What was driving the growth of the Lateral Flow Assay Component Market?

Ans - The Lateral Flow Assay Component Market was being driven by rising demand for rapid diagnostic testing and home-based healthcare solutions. 

2)    Which product type was leading the Lateral Flow Assay Component Market?

Ans - Membranes were leading the Lateral Flow Assay Component Market in 2025 with strong demand for accurate sample flow control. 

3)    How was technology influencing the Lateral Flow Assay Component Market?

Ans - The Lateral Flow Assay Component Market was integrating digital readers and multiplex detection to improve accuracy and efficiency 

4)    What challenges were affecting the Lateral Flow Assay Component Market?

Ans - The Lateral Flow Assay Component Market was facing raw material price volatility and stricter regulatory compliance standards.

Which region was leading the Lateral Flow Assay Component Market?

Ans - North America was leading the Lateral Flow Assay Component Market with advanced diagnostic infrastructure and strong R&D activities.

Report Payment

Single User:
$4199
Spreadsheet:
$2900
Corporate User:
$5500
bottom of page